Oral administration of probiotics ameliorated HFD-induced NAFLD in rats via increased generation of SCFAs and increased FFAR2 expression (Liang, Liang et al., 2019). This evidence concerns the gene FFAR2 and metabolic dysfunction-associated steatotic liver disease.